Computer system validation in Hong Kong that holds up under audit, not just at go-live

We plan, execute, and document the validation of your computerized systems against GxP for pharma, biotech and healthcare teams in Hong Kong and across APAC, so every result is accurate, every record is traceable, and every system holds up the moment a regulator asks how you know. From risk assessment through periodic review, compliance is built into the system, not bolted on before an inspection.

Validating systems for global life sciences leaders

Roche
Amgen
Pfizer
DKSH

Systems we validate

SAP HANA
Veeva
ArisGlobal
Medidata
Salesforce
Microsoft Dynamics 365

GxP compliance rests on four disciplines

Whatever the system and whatever the regulation, a validation program that actually holds up under audit comes back to the same four things, done consistently rather than once. That applies whether you supply Hong Kong under PIC/S GMP, or export to mainland China, the EU or the US.

Document

Every requirement, test script, deviation, and result is captured with a full, timestamped audit trail, so “it works” is never just a claim.

Qualify

Installation, Operational, and Performance Qualification (IQ/OQ/PQ) prove the system does what its specification says, in the environment it actually runs in.

Secure Data

Data integrity controls built on ALCOA+ principles keep records attributable, legible, and accurate from the moment they’re captured to the day they’re archived.

Maintain

Periodic review and change control keep a validated system in a state of control long after go-live, not just on the day it was signed off.

The lifecycle below shows how these four disciplines map onto a real validation project, from the first requirement to final sign-off.

What we validate across the product lifecycle

From the lab to the patient, any computerized system that creates, changes or stores GxP data needs evidence that it works as intended. We validate new implementations, upgrades and systems already in use.

Quality & manufacturing

eQMS, document management, LIMS, MES and ERP modules such as SAP used in GxP-relevant processes.

Clinical systems

EDC, ePRO/eCOA, eTMF and trial management platforms, in line with ICH E6(R3) expectations for computerized systems.

Safety & pharmacovigilance

Safety databases, adverse event intake and case processing, including automated and AI-assisted steps.

Patient support platforms

Programmes that capture adverse events and patient data, including platforms we build and run ourselves, such as Pati™.

Cloud & SaaS

Supplier assessment, configuration verification and release control for vendor-hosted systems you don’t control directly.

Spreadsheets & small tools

GxP spreadsheets, reports and end-user tools, validated proportionately so they’re controlled without a full project.

The validation lifecycle, stage by stage

A rigorous V-model, applied consistently whether we’re validating a LIMS, an ERP module, or a patient-facing app.

User Requirements Specification

We work with your process owners to capture what the system must do, in testable, unambiguous language that becomes the backbone of every test that follows.

Functional & Design Specification

The vendor’s or your team’s design is checked line by line against the URS, with every requirement traced forward before a single test script is written.

Installation Qualification

We verify the system is installed correctly, in the right environment, with the right configuration, matching what was specified and nothing else.

Operational Qualification

Every function is tested against its specification, including edge cases and negative testing, with results captured as objective evidence, not summarized after the fact.

Performance Qualification

The system is proven under real operating conditions, with real users and real process data, that it consistently does what it’s meant to do in production.

Periodic Review & Change Control

Validation doesn’t end at go-live. We schedule periodic reviews and run every change through a controlled process, so the system stays in its validated state for as long as it’s in use.

Three pillars of a validation program that actually holds up

From the first requirement to the final signature.

  • URS, FS & DS authoring. We translate business and regulatory requirements into specifications your vendor and your auditors can both work from.
  • Protocol authoring & execution. IQ, OQ, and PQ protocols written to be executable, not just theoretical, then run and documented by qualified validation engineers.
  • Traceability matrix. Every requirement is traced through design, testing, and sign-off, so a gap is visible long before an inspector finds it.
Talk to our validation team

Documentation built for the standard you’re actually being measured against.

  • GAMP 5 categorization. Every system is risk-classified against GAMP 5 categories, so the depth of testing matches the actual risk, not a one-size-fits-all checklist.
  • 21 CFR Part 11 & EU Annex 11. Electronic records and signatures are assessed and documented against both frameworks, wherever your systems and data cross borders.
  • SOPs & validation master plans. We write the standard operating procedures and master plans that turn a one-off project into a repeatable, auditable program.
Read about our compliance standards

Compliance is a state you maintain, not a milestone you pass.

  • Periodic review. Scheduled reviews reassess a system’s validated state against how it’s actually being used, catching drift before it becomes a finding.
  • Change control. Every patch, configuration change, or upgrade is impact-assessed and, where needed, re-validated before it goes live.
  • Data integrity & ALCOA+. Access controls, audit trails, and data governance are reviewed against ALCOA+ principles, not just at validation, but for the life of the system.
Talk to our compliance team

Built to the standards regulators actually check

Whether we’re validating a LIMS, an ERP module, or a patient-facing app, these are the frameworks every validation package is measured against, mapped to the markets your products and data reach.

21 CFR Part 11

Electronic records and electronic signatures are assessed for authenticity, integrity, and confidentiality, matching the FDA’s requirements for computerized systems used in regulated processes.

EU Annex 11

For systems and data crossing into the EU, we validate against Annex 11’s requirements for computerized systems, including supplier assessment and data integrity throughout the system lifecycle.

PIC/S GMP

The inspection standard followed in Hong Kong and by many APAC regulators, including its guidance on computerized systems and data integrity.

ICH E6(R3) & FDA CSA

Good Clinical Practice expectations for fit-for-purpose, validated trial systems, and the FDA’s risk-based Computer Software Assurance thinking: effort focused where failure would matter most.

ALCOA+ Data Integrity

Attributable, legible, contemporaneous, original, and accurate, plus complete, consistent, enduring, and available: we build data integrity controls around all nine principles, not just the headline five.

The people behind the validation

MK

Mike Kwok

Founding Director

in

Mike aligns validation programs with real regulatory and business risk. With 14+ years of technology consulting experience, he has guided pharma and healthcare clients through system implementations that had to be right the first time.

TT

Tom Tsang

Systems Architect

Tom designs the technical backbone of every validated system we touch, from LIMS integrations to ERP configurations, so the architecture itself is built to hold up under IQ, OQ, and PQ.

RL

Rachel Li

Compliance & Data Governance

Rachel leads our compliance and data governance practice, translating GAMP 5, 21 CFR Part 11, and Annex 11 into documentation and controls that pass both internal QA review and regulatory inspection.

Computer system validation: common questions

Computer system validation is documented evidence that a computerized system used in a GxP process does what it is intended to do, consistently, and protects the integrity of the data it handles. Regulators in Hong Kong, the EU and the US expect it for any system that affects product quality, patient safety or regulated records.

Yes. Our validation team is based in Kowloon Bay, Hong Kong, and works with pharma, biotech and healthcare organisations in Hong Kong and across APAC, in English and Chinese, on site or remotely.

Installation Qualification (IQ) confirms the system is installed correctly. Operational Qualification (OQ) confirms each function works as specified. Performance Qualification (PQ) confirms the system performs consistently under real operating conditions, with real users and real data.

Computer Software Assurance (CSA) is the US FDA’s risk-based approach to assuring production and quality system software. It shifts effort from documentation towards critical thinking and testing focused on high-risk functions. It complements, rather than replaces, the risk-based principles in GAMP 5, and we apply the same thinking across our projects.

GAMP 5’s risk-based categorization is built for exactly this question. We assess each system against its intended use and regulatory impact first, then size the validation effort to match, rather than applying the same depth of testing everywhere.

Yes. For vendor-hosted systems we assess the supplier, leverage their documented testing where it is reliable, verify your configuration, and put controls in place for the vendor’s release cycle.

It depends on system complexity and GAMP 5 category, from a few weeks for a low-risk, configured off-the-shelf tool to several months for a bespoke, high-risk system with complex integrations. We scope timelines against your go-live date early, not after testing has already started.

The system enters periodic review and change control. Every patch, configuration change, or upgrade is impact-assessed, and where needed, re-validated, so the system stays in its validated state for as long as it’s in use.

Yes. Retrospective validation and remediation of legacy systems is common work for us, particularly ahead of an audit or after a gap has been identified internally.

Further reading: medicine innovation in Hong Kong and why CSV matters, CSV best practices in pharma and designing safe patient data systems.

Ready to bring your systems into a validated, audit-ready state?

Tell us which systems you’re running and where you are in the lifecycle. Our Hong Kong validation team will show you the fastest compliant path to sign-off.

Talk to our validation team
Scroll to Top